newsfilter
← Latest News
GlobeNewswire·

Cocrystal Pharma Provides Business Update and Reports First Quarter 2026 Financial Results

Completed enrollment in first cohort of Phase 1b challenge study evaluating CDI-988 as a preventive and as a treatment for norovirus infection, began enrollment in prevention and treatment cohortsHighlighted CDI-988's